Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-25-036721
Filing Date
2025-07-30
Accepted
2025-07-30 16:14:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 primemedicineprelim424b5ju.htm 424B5 469729
2 primemedlogoa.jpg GRAPHIC 36675
3 prospectusa.jpg GRAPHIC 14048
  Complete submission text file 0001628280-25-036721.txt   540709
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275321 | Film No.: 251167212
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)